Qiu Yan, Yin Xuewei, Guo Lijie, Wang Baojian, Zhang Miao, Xu Shuqin, Wei Huixia, Liu Bin, Gao Yane, Bi Hongsheng, Guo Dadong
Department of Rheumatology and Immunology, The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan 250002, China.
Departement of Central Laboratory, Affiliated Eye Hospital of Shandong University of Traditional Chinese Medicine, Jinan 250002, China.
Mediators Inflamm. 2025 Aug 28;2025:8824838. doi: 10.1155/mi/8824838. eCollection 2025.
Uveitis is an inflammatory eye disease, and Longdan Xiegan Decoction (LXD) has been used to treat uveitis. However, the underlying mechanisms have not fully been addressed. The present study aimed to provide new insights into LXD ameliorating inflammatory response of experimental autoimmune uveitis (EAU) and regulating T helper (Th) cell differentiation via the interaction between microRNA (miRNA) and mRNA. The hub genes, corresponding miRNAs, and bioactive substances from the LXD formula that are involved in ameliorating uveitis were identified through the network pharmacology analysis. We investigated the efficacy of LXD on the pathogenesis of EAU in vivo using the Genesis-D camera and histopathological examination, and confirmed the inhibitory effect of miR-30b-5p on the Notch signaling pathway in vitro. The analysis results indicated that T-cell lineage commitment and the Notch signaling pathway activation are the primary inflammatory process associated with the therapeutic effects of LXD on uveitis. Further predictions revealed the miRNA-mRNA interactions between miR-30b-5p and the mRNAs associated with Notch1 and DLL4. The pathogenesis of uveitis involves elevated Notch1, DLL4, IL-17A, and RORγt, and decreased levels of miR-30b-5p. LXD can enhance miR-30b-5p expression, inhibit Notch signaling activation, and suppress the commitment of uveitogenic T-cell lineages. Additionally, it downregulates proinflammatory cytokines while upregulating antiinflammatory cytokines, thereby promoting the the expansion of Treg and Th2 cell lineages, and restoring the ratios of Th1/Th2 and Th17/Treg cells. Reduced expression of miR-30b-5p contributes to the pathogenesis of uveitis. LXD exhibited an inhibitory effect on Notch signaling activation through the miR-30b-5p upregulation and the regulation of the balance between Th1/Th2 and Th17/Treg cell differentiation, ultimately facilitating the treatment of uveitis.
葡萄膜炎是一种炎症性眼病,龙胆泻肝汤(LXD)已被用于治疗葡萄膜炎。然而,其潜在机制尚未完全阐明。本研究旨在通过微小RNA(miRNA)与信使核糖核酸(mRNA)之间的相互作用,为LXD改善实验性自身免疫性葡萄膜炎(EAU)的炎症反应和调节辅助性T(Th)细胞分化提供新的见解。通过网络药理学分析确定了LXD方剂中参与改善葡萄膜炎的关键基因、相应的miRNA和生物活性物质。我们使用Genesis-D相机和组织病理学检查在体内研究了LXD对EAU发病机制的疗效,并在体外证实了miR-30b-5p对Notch信号通路的抑制作用。分析结果表明,T细胞谱系定向分化和Notch信号通路激活是与LXD治疗葡萄膜炎疗效相关的主要炎症过程。进一步的预测揭示了miR-30b-5p与Notch1和DLL4相关mRNA之间的miRNA-mRNA相互作用。葡萄膜炎的发病机制涉及Notch1、DLL4、白细胞介素-17A(IL-17A)和维甲酸相关孤儿受体γt(RORγt)水平升高,以及miR-30b-5p水平降低。LXD可增强miR-30b-5p表达,抑制Notch信号激活,并抑制致葡萄膜炎性T细胞谱系的定向分化。此外,它下调促炎细胞因子,同时上调抗炎细胞因子,从而促进调节性T细胞(Treg)和Th2细胞谱系的扩增,并恢复Th1/Th2和Th17/Treg细胞的比例。miR-30b-5p表达降低促成了葡萄膜炎的发病机制。LXD通过上调miR-